Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals.
- DOI
- 10.1016/j.jim.2024.113683
- Published
- 2024 Jul
- Container
- Journal of immunological methods
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jim.2024.113683,
title = {Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals.},
author = {da Costa HHM and Silva VO and Amorim GC and Guereschi MG and Sergio LM and Gomes CHR and Hong MA and de Oliveira EL and Brígido LFM and Lindoso JAL and Prudencio CR},
year = {2024},
journal = {Journal of immunological methods},
doi = {10.1016/j.jim.2024.113683},
url = {https://doi.org/10.1016/j.jim.2024.113683}
}RIS
TY - JOUR TI - Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals. AU - da Costa HHM AU - Silva VO AU - Amorim GC AU - Guereschi MG AU - Sergio LM AU - Gomes CHR AU - Hong MA AU - de Oliveira EL AU - Brígido LFM AU - Lindoso JAL AU - Prudencio CR PY - 2024 JO - Journal of immunological methods DO - 10.1016/j.jim.2024.113683 UR - https://doi.org/10.1016/j.jim.2024.113683 ER -
APA
HHM, D. C., VO, S., GC, A., MG, G., LM, S., CHR, G., MA, H., EL, D. O., LFM, B., JAL, L., & CR, P. (2024). Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals.. Journal of immunological methods. https://doi.org/10.1016/j.jim.2024.113683
Source records
- pubmed · retrieved 2026-09-26T21:48:15.085Z